Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?

Bendjelid, Karim

doi:10.1186/s13054-020-03144-6

Scientific article

Comment

English

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?

ContributorsBendjelid, Karim

Published inCritical Care, vol. 24, no. 1, 407

Publication date2020

Keywords

Angiotensin II
Betacoronavirus
Coronavirus Infections
Humans
Pandemics
Pneumonia
Viral

Affiliation entities

Faculté de médecine / Section de médecine clinique / Département d'anesthésiologie, pharmacologie, soins intensifs et urgences

Research groups

Groupe de recherche en hémodynamique (913)

Citation (ISO format)

BENDJELID, Karim. Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock? In: Critical Care, 2020, vol. 24, n° 1, p. 407. doi: 10.1186/s13054-020-03144-6

Article (Published version)

CC BY

Identifiers

PID : unige:142402
DOI : 10.1186/s13054-020-03144-6
PMID : 32646518

Commercial URLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7347253/

Journal ISSN1364-8535

232views

108downloads

Creation12/08/2020 16:31:00

First validation12/08/2020 16:31:00

Update time27/06/2024 08:59:18

Status update15/03/2023 22:42:04

Last indexation31/10/2024 19:51:04

Archive ouverte UNIGE

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?

Technical informations